Next Article in Journal
Implications of Antibiotic Use during the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America
Previous Article in Journal
Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review
Due to scheduled maintenance work on our core network, there may be short service disruptions on this website between 16:00 and 16:30 CEST on September 25th.
Perspective

Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease

Alzheimer’s Germ Quest, 4301 Gulfshore Blvd. N., Suite 1404, Naples, FL 34103, USA
Academic Editor: Nicholas Dixon
Received: 28 January 2021 / Revised: 18 March 2021 / Accepted: 18 March 2021 / Published: 20 March 2021
There is now considerable evidence that several infectious agents (viruses, bacteria, or parasites) may play a contributing role in the development of Alzheimer’s disease (AD). The six primary suspects are herpes viruses, spirochetal bacteria, Chlamydia pneumoniae, Porphyromonas gingivalis, mycobacteria, and toxoplasma parasites. Also, some of the antimicrobial and antiviral agents that are used to treat them have shown promise for AD interventions. I describe this evidence and assert it is now time to accelerate clinical trials of these existing drugs, already federally approved, to determine if such treatments can delay, halt, or reverse AD. View Full-Text
Keywords: Alzheimer’s disease; dementia; beta-amyloid; germ theory; drug development; clinical trials; herpes; spirochetes; Chlamydia pneumoniae; Porphyromonas gingivalis; toxoplasma; mycobacteria Alzheimer’s disease; dementia; beta-amyloid; germ theory; drug development; clinical trials; herpes; spirochetes; Chlamydia pneumoniae; Porphyromonas gingivalis; toxoplasma; mycobacteria
MDPI and ACS Style

Norins, L.C. Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease. Antibiotics 2021, 10, 327. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10030327

AMA Style

Norins LC. Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease. Antibiotics. 2021; 10(3):327. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10030327

Chicago/Turabian Style

Norins, Leslie C. 2021. "Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease" Antibiotics 10, no. 3: 327. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10030327

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop